Literature DB >> 20821001

Several conserved positively charged amino acids in OATP1B1 are involved in binding or translocation of different substrates.

Yi M Weaver1, Bruno Hagenbuch.   

Abstract

OATP1B1 and 1B3 are related transporters mediating uptake of numerous compounds into hepatocytes. A putative model of OATP1B3 with a "positive binding pocket" containing conserved positively charged amino acids was predicted (Meier-Abt et al. J Membr Biol 208:213-227, 2005). Based on this model, we tested the hypothesis that these positive amino acids are important for OATP1B1 function. We made mutants and measured surface expression and uptake of estradiol-17β-glucuronide, estrone-3-sulfate and bromosulfophthalein in HEK293 cells. Two of the mutants had low surface expression levels: R181K at 10% and R580A at 30% of wild-type OATP1B1. A lysine at position 580 (R580K) rescued the expression of R580A. Mutations of several amino acids resulted in substrate-dependent effects. The largest changes were seen for estradiol-17β-glucuronide, while estrone-3-sulfate and bromosulfophthalein transport were less affected. The wild-type OATP1B1 K (m) value for estradiol-17β-glucuronide of 5.35 ± 0.54 μM was increased by R57A to 30.5 ± 3.64 μM and decreased by R580K to 0.52 ± 0.18 μM. For estrone-3-sulfate the wild-type high-affinity K (m) value of 0.55 ± 0.12 μM was increased by K361R to 1.8 ± 0.47 μM and decreased by R580K to 0.1 ± 0.04 μM. In addition, R580K reduced the V (max) values for all three substrates to <25% of wild-type OATP1B1. Mutations at intracellular K90, H92 and R93 mainly affected V (max) values for estradiol-17β-glucuronide uptake. In conclusion, the conserved amino acids R57, K361 and R580 seem to be part of the substrate binding sites and/or translocation pathways in OATP1B1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20821001      PMCID: PMC2989658          DOI: 10.1007/s00232-010-9300-3

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  43 in total

1.  Structure and mechanism of the lactose permease of Escherichia coli.

Authors:  Jeff Abramson; Irina Smirnova; Vladimir Kasho; Gillian Verner; H Ronald Kaback; So Iwata
Journal:  Science       Date:  2003-08-01       Impact factor: 47.728

2.  Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects.

Authors:  Ichiro Ieiri; Hiroshi Suzuki; Miyuki Kimura; Hiroshi Takane; Yohei Nishizato; Shin Irie; Akinori Urae; Kiyoshi Kawabata; Shun Higuchi; Kenji Otsubo; Yuichi Sugiyama
Journal:  Hepatol Res       Date:  2004-10       Impact factor: 4.288

Review 3.  Pharmacogenomics of human OATP transporters.

Authors:  Jörg König; Annick Seithel; Ulrike Gradhand; Martin F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-09       Impact factor: 3.000

4.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

Authors:  I Tamai; J Nezu; H Uchino; Y Sai; A Oku; M Shimane; A Tsuji
Journal:  Biochem Biophys Res Commun       Date:  2000-06-24       Impact factor: 3.575

5.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

Authors:  T Abe; M Unno; T Onogawa; T Tokui; T N Kondo; R Nakagomi; H Adachi; K Fujiwara; M Okabe; T Suzuki; K Nunoki; E Sato; M Kakyo; T Nishio; J Sugita; N Asano; M Tanemoto; M Seki; F Date; K Ono; Y Kondo; K Shiiba; M Suzuki; H Ohtani; T Shimosegawa; K Iinuma; H Nagura; S Ito; S Matsuno
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

6.  A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.

Authors:  B Hsiang; Y Zhu; Z Wang; Y Wu; V Sasseville; W P Yang; T G Kirchgessner
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

7.  1199G>A and 2677G>T/A polymorphisms of ABCB1 independently affect tacrolimus concentration in hepatic tissue after liver transplantation.

Authors:  Laure Elens; Arnaud Capron; Valérie Van Kerckhove; Jan Lerut; Michel Mourad; Dominique Lison; Pierre Wallemacq; Vincent Haufroid
Journal:  Pharmacogenet Genomics       Date:  2007-10       Impact factor: 2.089

8.  OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.

Authors:  Wei Zhang; Yi-Jing He; Zhou Gan; Lan Fan; Qing Li; An Wang; Zhao-Qian Liu; Sheng Deng; Yuan-Fei Huang; Lin-Yong Xu; Hong-Hao Zhou
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-12       Impact factor: 2.557

9.  The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.

Authors:  Mayuko Miyagawa; Kazuya Maeda; Akinori Aoyama; Yuichi Sugiyama
Journal:  J Pharmacol Exp Ther       Date:  2009-02-24       Impact factor: 4.030

10.  Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.

Authors:  Stefan Oswald; Jörg König; Dieter Lütjohann; Thomas Giessmann; Heyo K Kroemer; Christian Rimmbach; Dieter Rosskopf; Martin F Fromm; Werner Siegmund
Journal:  Pharmacogenet Genomics       Date:  2008-07       Impact factor: 2.089

View more
  14 in total

1.  Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition.

Authors:  Laura B Ramsey; Gitte H Bruun; Wenjian Yang; Lisa R Treviño; Selina Vattathil; Paul Scheet; Cheng Cheng; Gary L Rosner; Kathleen M Giacomini; Yiping Fan; Alex Sparreboom; Torben S Mikkelsen; Thomas J Corydon; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Genome Res       Date:  2011-12-06       Impact factor: 9.043

2.  Interactions of green tea catechins with organic anion-transporting polypeptides.

Authors:  Megan Roth; Barbara N Timmermann; Bruno Hagenbuch
Journal:  Drug Metab Dispos       Date:  2011-01-28       Impact factor: 3.922

Review 3.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity.

Authors:  Marianne K DeGorter; Richard H Ho; Brenda F Leake; Rommel G Tirona; Richard B Kim
Journal:  Mol Pharm       Date:  2012-03-06       Impact factor: 4.939

5.  The Importance of Val386 in Transmembrane Domain 8 for the Activation of OATP1B3 by Epigallocatechin Gallate.

Authors:  Zhongmin Wang; Ying Li; Cecilia E Villanueva; Taotao Peng; Wanjun Han; Zheyue Bo; Hongjian Zhang; Bruno Hagenbuch; Chunshan Gui
Journal:  J Agric Food Chem       Date:  2022-05-22       Impact factor: 5.895

Review 6.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

Review 7.  Organic anion-transporting polypeptides.

Authors:  Bruno Stieger; Bruno Hagenbuch
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

Review 8.  The SLCO (former SLC21) superfamily of transporters.

Authors:  Bruno Hagenbuch; Bruno Stieger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

9.  Data-Driven Ensemble Docking to Map Molecular Interactions of Steroid Analogs with Hepatic Organic Anion Transporting Polypeptides.

Authors:  Alzbeta Tuerkova; Orsolya Ungvári; Réka Laczkó-Rigó; Erzsébet Mernyák; Gergely Szakács; Csilla Özvegy-Laczka; Barbara Zdrazil
Journal:  J Chem Inf Model       Date:  2021-06-09       Impact factor: 4.956

10.  Identification of amino acids essential for estrone-3-sulfate transport within transmembrane domain 2 of organic anion transporting polypeptide 1B1.

Authors:  Nan Li; Weifang Hong; Hong Huang; Hanping Lu; Guangyun Lin; Mei Hong
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.